BioNTech’s ‘extensive’ cancer pipeline comes into focus, with emphasis on ADCs

BioNTech, one of the biotech startups that helped vaccinate billions of people around the world against Covid-19, is starting to look like a cancer company.

The company’s executives spent four hours running through their cancer programs at BioNTech’s Innovation Day on Tuesday, discussing data from a variety of antibody-drug conjugates,…
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks